TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/19/25 19:11 | 2/18/25 | VIR | Vir Biotechnology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Scangos George A | CA | D | S | -108 | 9.81 | 0 | -11 | 0 | 3,824 | D | |||||||||||||||
2/26/24 19:30 | 2/22/24 | VIR | Vir Biotechnology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Scangos George A | CA | D | S.m | -307 | 11.07 | 0 | -28 | -1 | 3,827 | D | |||||||||||||||
2/20/24 21:02 | 2/16/24 | VIR | Vir Biotechnology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Scangos George A | CA | D | S.m | -284 | 10.23 | 0 | -28 | -1 | 3,854 | D | |||||||||||||||
2/24/23 20:34 | 2/23/23 | VIR | Vir Biotechnology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Scangos George A | CA | DO | P,CEO | S.m | -681 | 24.53 | 0 | -28 | 0 | 5,760 | D | ||||||||||||||
2/21/23 19:29 | 2/17/23 | VIR | Vir Biotechnology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Scangos George A | CA | DO | P,CEO | S.m | -756 | 27.23 | 0 | -28 | -7 | 376 | M |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |